ChemopreventionPalpationBreastTomosynthesisMultimodalityTherapyEndometrialCancerOligometastases1 in 8womenMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be felt5-FluorouracilCMFChemotherapyKappaEpsilonCachexiaMastitisPARPInhibitorsAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenMastalgiaDocetaxelMetastaticBreastCancerPhyllodesTumorLiquidBiopsylatissimusflapTamoxifenGenomicTestingPagetDiseaseMRICapecitabineECOGScoreBI-RADSACChemotherapyTumorGradeEvidencesuggests thatphysical activitymay reduce therisk of breastcancersMethotrexateFISHER-Disease-FreeSurvivalRateRelapseAntiemeticFlowCytometryLCISMolecularBreastImagingMastodyniaAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerNodePositiveTripleNegativeBreastCancerAyurvedaDoseDenseTherapyBilateralProphylacticMastectomyAnastrozoleHormoneReplacementTherapySelf-examinationRadiotherapyBiopsyPathologicResponseOophorectomyEstradiolMetastasisWomen ages40+ shouldhave a clinicalbreast examat least yearlyHER-2NodeNegativeGailModelMorpheaNeoadjuvantTherapyOvarianSuppressionFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.HormoneReceptorStatusDiabeticMastopathymTORInhibitorsEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearApoptosisStagingLymphNodeStatusTriplePositiveBreastCancerFibroadenomaGeneticCounselingKi-67RateAdjuvantTherapyCyclophosphamideChemotherapyInvasiveBreastCancerRADCAMEstrogenGeneMutationPalbociclibER+Breast cancer isthe leading causeof death in womenbetween the agesof 40 and 55PrecisionMedicineAlopeciaLapatinibProgestinNeoplasmPaclitaxelSclerosingAdenosisImmunotherapyCDK4/6InhibitorsAdvocacyDown-StagingAdenocarcinomaBreastCancerBrachytherapyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.DimplingPI3KinaseInhibitorsTyrosine-KinaseInhibitorDefinitiveSurgeryGermlineMutationAromataseInhibitorsMegestrolAcetateCalcificationsMastectomyMultifocalTumorsAbsoluteRiskLumpectomyGuaranteedRenewableInsuranceCo-survivorIn-situCarcinomaRaloxifeneLumpHerceptinCystAxillarySamplingAntibodyTherapyBRCAGeneFamilyHistoryCytostaticCytotoxicExcisionalBiopsyCheckpointInhibitorBevacizumabBOCAEGFR(epidermalgrowth factorreceptor)BenignPhyllodesTumorSERMDoxorubicinAngiogenesisLymphoscintigraphyGeneticPredispositionIntraductalPapillomaChemopreventionPalpationBreastTomosynthesisMultimodalityTherapyEndometrialCancerOligometastases1 in 8womenMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be felt5-FluorouracilCMFChemotherapyKappaEpsilonCachexiaMastitisPARPInhibitorsAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenMastalgiaDocetaxelMetastaticBreastCancerPhyllodesTumorLiquidBiopsylatissimusflapTamoxifenGenomicTestingPagetDiseaseMRICapecitabineECOGScoreBI-RADSACChemotherapyTumorGradeEvidencesuggests thatphysical activitymay reduce therisk of breastcancersMethotrexateFISHER-Disease-FreeSurvivalRateRelapseAntiemeticFlowCytometryLCISMolecularBreastImagingMastodyniaAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerNodePositiveTripleNegativeBreastCancerAyurvedaDoseDenseTherapyBilateralProphylacticMastectomyAnastrozoleHormoneReplacementTherapySelf-examinationRadiotherapyBiopsyPathologicResponseOophorectomyEstradiolMetastasisWomen ages40+ shouldhave a clinicalbreast examat least yearlyHER-2NodeNegativeGailModelMorpheaNeoadjuvantTherapyOvarianSuppressionFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.HormoneReceptorStatusDiabeticMastopathymTORInhibitorsEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearApoptosisStagingLymphNodeStatusTriplePositiveBreastCancerFibroadenomaGeneticCounselingKi-67RateAdjuvantTherapyCyclophosphamideChemotherapyInvasiveBreastCancerRADCAMEstrogenGeneMutationPalbociclibER+Breast cancer isthe leading causeof death in womenbetween the agesof 40 and 55PrecisionMedicineAlopeciaLapatinibProgestinNeoplasmPaclitaxelSclerosingAdenosisImmunotherapyCDK4/6InhibitorsAdvocacyDown-StagingAdenocarcinomaBreastCancerBrachytherapyWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.DimplingPI3KinaseInhibitorsTyrosine-KinaseInhibitorDefinitiveSurgeryGermlineMutationAromataseInhibitorsMegestrolAcetateCalcificationsMastectomyMultifocalTumorsAbsoluteRiskLumpectomyGuaranteedRenewableInsuranceCo-survivorIn-situCarcinomaRaloxifeneLumpHerceptinCystAxillarySamplingAntibodyTherapyBRCAGeneFamilyHistoryCytostaticCytotoxicExcisionalBiopsyCheckpointInhibitorBevacizumabBOCAEGFR(epidermalgrowth factorreceptor)BenignPhyllodesTumorSERMDoxorubicinAngiogenesisLymphoscintigraphyGeneticPredispositionIntraductalPapilloma

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
  1. Chemoprevention
  2. Palpation
  3. Breast Tomosynthesis
  4. Multimodality Therapy
  5. Endometrial Cancer
  6. Oligometastases
  7. 1 in 8 women
  8. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  9. 5-Fluorouracil
  10. CMF Chemotherapy
  11. Kappa Epsilon
  12. Cachexia
  13. Mastitis
  14. PARP Inhibitors
  15. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  16. Mastalgia
  17. Docetaxel
  18. Metastatic Breast Cancer
  19. Phyllodes Tumor
  20. Liquid Biopsy
  21. latissimus flap
  22. Tamoxifen
  23. Genomic Testing
  24. Paget Disease
  25. MRI
  26. Capecitabine
  27. ECOG Score
  28. BI-RADS
  29. AC Chemotherapy
  30. Tumor Grade
  31. Evidence suggests that physical activity may reduce the risk of breast cancers
  32. Methotrexate
  33. FISH
  34. ER-
  35. Disease-Free Survival Rate
  36. Relapse
  37. Antiemetic
  38. Flow Cytometry
  39. LCIS
  40. Molecular Breast Imaging
  41. Mastodynia
  42. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  43. Node Positive
  44. Triple Negative Breast Cancer
  45. Ayurveda
  46. Dose Dense Therapy
  47. Bilateral Prophylactic Mastectomy
  48. Anastrozole
  49. Hormone Replacement Therapy
  50. Self-examination
  51. Radiotherapy
  52. Biopsy
  53. Pathologic Response
  54. Oophorectomy
  55. Estradiol
  56. Metastasis
  57. Women ages 40+ should have a clinical breast exam at least yearly
  58. HER-2
  59. Node Negative
  60. Gail Model
  61. Morphea
  62. Neoadjuvant Therapy
  63. Ovarian Suppression
  64. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  65. Hormone Receptor Status
  66. Diabetic Mastopathy
  67. mTOR Inhibitors
  68. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  69. Apoptosis
  70. Staging
  71. Lymph Node Status
  72. Triple Positive Breast Cancer
  73. Fibroadenoma
  74. Genetic Counseling
  75. Ki-67 Rate
  76. Adjuvant Therapy
  77. Cyclophosphamide
  78. Chemotherapy
  79. Invasive Breast Cancer
  80. RAD
  81. CAM
  82. Estrogen
  83. Gene Mutation
  84. Palbociclib
  85. ER+
  86. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  87. Precision Medicine
  88. Alopecia
  89. Lapatinib
  90. Progestin
  91. Neoplasm
  92. Paclitaxel
  93. Sclerosing Adenosis
  94. Immunotherapy
  95. CDK4/6 Inhibitors
  96. Advocacy
  97. Down-Staging
  98. Adenocarcinoma
  99. Breast Cancer
  100. Brachytherapy
  101. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  102. Dimpling
  103. PI3 Kinase Inhibitors
  104. Tyrosine-Kinase Inhibitor
  105. Definitive Surgery
  106. Germline Mutation
  107. Aromatase Inhibitors
  108. Megestrol Acetate
  109. Calcifications
  110. Mastectomy
  111. Multifocal Tumors
  112. Absolute Risk
  113. Lumpectomy
  114. Guaranteed Renewable Insurance
  115. Co-survivor
  116. In-situ Carcinoma
  117. Raloxifene
  118. Lump
  119. Herceptin
  120. Cyst
  121. Axillary Sampling
  122. Antibody Therapy
  123. BRCA Gene
  124. Family History
  125. Cytostatic
  126. Cytotoxic
  127. Excisional Biopsy
  128. Checkpoint Inhibitor
  129. Bevacizumab
  130. BOCA
  131. EGFR (epidermal growth factor receptor)
  132. Benign Phyllodes Tumor
  133. SERM
  134. Doxorubicin
  135. Angiogenesis
  136. Lymphoscintigraphy
  137. Genetic Predisposition
  138. Intraductal Papilloma